首页> 美国卫生研究院文献>Oncotarget >P-cadherin signals through the laminin receptor α6β4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells
【2h】

P-cadherin signals through the laminin receptor α6β4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells

机译:P-钙黏着蛋白通过层粘连蛋白受体α6β4整合素发出信号诱导基底样乳腺癌细胞的干细胞和侵袭特性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

P-cadherin is a classical cell-cell adhesion molecule that, in contrast to E-cadherin, has a positive role in breast cancer progression, being considered a poor prognostic factor in this disease. In previous reports, we have shown that this protein induces cancer stem cell and invasive properties to basal-like breast cancer cells. Here, we clarify the downstream signaling pathways that are triggered by P-cadherin to mediate these effects.We demonstrated that P-cadherin inhibition led to a significant decreased adhesion of cancer cells to the basement membrane substrate laminin, as well as to a major reduction in the expression of the laminin receptor α6β4 integrin. Remarkably, the expression of this heterodimer was required for the invasive capacity and increased mammosphere forming efficiency induced by P-cadherin expression. Moreover, we showed that P-cadherin transcriptionally up-regulates the α6 integrin subunit expression and directly interacts with the β4 integrin subunit. We still showed that P-cadherin downstream signaling, in response to laminin, involves the activation of focal adhesion (FAK), Src and AKT kinases. The association between the expression of P-cadherin, α6β4 heterodimer and the active FAK and Src phosphorylated forms was validated in vivo.Our data establish that there is a crosstalk between P-cadherin and the laminin receptor α6β4 integrin signaling pathway, which link has never been previously described. The activation of this heterodimer explains the stem cell and invasive properties induced by P-cadherin to breast cancer cells, pointing to a new molecular mechanism that may be targeted to counteract the effects induced by this adhesion molecule.
机译:P-钙粘着蛋白是经典的细胞-细胞粘附分子,与E-钙粘着蛋白相反,在乳腺癌的进展中具有积极作用,被认为是该疾病的不良预后因素。在以前的报告中,我们已经表明,这种蛋白质可诱导癌干细胞和对基底样乳腺癌细胞的侵袭特性。在这里,我们阐明了由P-钙粘蛋白触发的下游信号传导通路来介导这些作用。我们证明了P-钙粘蛋白的抑制作用导致癌细胞对基底膜底物层粘连蛋白的粘附力显着降低,并且导致了主要的降低。在层粘连蛋白受体α6β4整联蛋白的表达中的表达。显着地,该异二聚体的表达对于P-钙粘着蛋白表达诱导的侵袭能力和增加的乳球形成效率是必需的。而且,我们表明P-钙粘着蛋白在转录上上调α6整联蛋白亚基的表达并直接与β4整联蛋白亚基相互作用。我们仍然显示,对层粘连蛋白的响应,P-钙粘蛋白下游信号传导涉及粘着斑粘附(FAK),Src和AKT激酶的激活。在体内验证了P-钙粘蛋白,α6β4异二聚体的表达与活性FAK和Src磷酸化形式之间的关联。我们的数据建立了P-钙粘蛋白与层粘连蛋白受体α6β4整联蛋白信号通路之间的串扰,以前从未描述过哪个链接。该异二聚体的活化解释了P-钙粘着蛋白诱导的对乳腺癌细胞的干细胞和侵袭特性,指出了一种新的分子机制,可以靶向抵消这种粘附分子诱导的效应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号